S. Gili, F. Cannata, M. Muratori, G. Santagostino Baldi, G. Teruzzi, G. Calligaris, D. Trabattoni
{"title":"使用Memopart™闭塞装置经皮封闭复杂解剖结构的卵圆孔未闭","authors":"S. Gili, F. Cannata, M. Muratori, G. Santagostino Baldi, G. Teruzzi, G. Calligaris, D. Trabattoni","doi":"10.1016/j.ahjo.2025.100613","DOIUrl":null,"url":null,"abstract":"<div><div>We conducted a single center observational study aimed to assess safety and efficacy of Balmed Memopart PFO occluder in treatment of complex PFO anatomies including at least one of the following: tunnel length ≥ 8 mm, atrial septal aneurysm, lipomatous hypertrophy of fossa ovalis rims (≥10 mm), cribriform or additional multiple small defects on the fossa ovalis, residual large Eustachian ridge or Chiari network. This analysis demonstrated Memopart PFO occluder device to be a safe and effective option for PFO closure, with good procedural success rate (100 %) and no significant safety issues (1 mild residual shunt at 24 h).</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"59 ","pages":"Article 100613"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Percutaneous closure of patent foramen ovale with complex anatomy using the Memopart™ occluder device\",\"authors\":\"S. Gili, F. Cannata, M. Muratori, G. Santagostino Baldi, G. Teruzzi, G. Calligaris, D. Trabattoni\",\"doi\":\"10.1016/j.ahjo.2025.100613\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>We conducted a single center observational study aimed to assess safety and efficacy of Balmed Memopart PFO occluder in treatment of complex PFO anatomies including at least one of the following: tunnel length ≥ 8 mm, atrial septal aneurysm, lipomatous hypertrophy of fossa ovalis rims (≥10 mm), cribriform or additional multiple small defects on the fossa ovalis, residual large Eustachian ridge or Chiari network. This analysis demonstrated Memopart PFO occluder device to be a safe and effective option for PFO closure, with good procedural success rate (100 %) and no significant safety issues (1 mild residual shunt at 24 h).</div></div>\",\"PeriodicalId\":72158,\"journal\":{\"name\":\"American heart journal plus : cardiology research and practice\",\"volume\":\"59 \",\"pages\":\"Article 100613\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American heart journal plus : cardiology research and practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666602225001168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal plus : cardiology research and practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666602225001168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Percutaneous closure of patent foramen ovale with complex anatomy using the Memopart™ occluder device
We conducted a single center observational study aimed to assess safety and efficacy of Balmed Memopart PFO occluder in treatment of complex PFO anatomies including at least one of the following: tunnel length ≥ 8 mm, atrial septal aneurysm, lipomatous hypertrophy of fossa ovalis rims (≥10 mm), cribriform or additional multiple small defects on the fossa ovalis, residual large Eustachian ridge or Chiari network. This analysis demonstrated Memopart PFO occluder device to be a safe and effective option for PFO closure, with good procedural success rate (100 %) and no significant safety issues (1 mild residual shunt at 24 h).